Literature DB >> 15968404

Thrombin activates the p21-activated kinase in pulmonary artery smooth muscle cells. Role in tissue factor expression.

Agnes Görlach1, Rachida S BelAiba, John Hess, Thomas Kietzmann.   

Abstract

The p21-activated serine/threonine kinases (PAK) play an important role in a variety of cellular functions. However, their role in the smooth muscle response to thrombin, which is activated upon vascular injury and promotes vascular remodelling processes, is not resolved. Here we investigated the role of PAK in thrombin signalling and regulation of tissue factor (TF), the activator of the extrinsic coagulation cascade, in pulmonary artery smooth muscle cells (PASMC), the main cell type responsible for vascular remodelling in pulmonary hypertension. PAK was rapidly phosphorylated in response to thrombin. Thrombin and active PAKT423E phosphorylated p38 MAP kinase (p38MAPK), ERK1/2, phosphatidylinositol-dependent kinase-1 (PDK1) and protein kinase B/Akt (PKB) whereas kinase-deficient PAK1 prevented activation of these kinases by thrombin. In addition, kinase- deficient MKK3 inhibited activation of PDK1 and PKB by thrombin. Further, thrombin and active PAK1 induced TF expression and promoter activity while kinase-deficient PAK1 diminished thrombin-induced TF upregulation. Moreover, kinase-deficient MKK3, PDK1 and PKB inhibited thrombin- and PAK-dependent TF expression and promoter activity. Together these findings show that PAK is a critical element of thrombin signalling in PASMC which is involved in the regulation of TF expression by sequentially activating MKK3/p38MAPK, PDK1 and PKB. Thus, PAK may play an important role in promoting vascular remodelling processes in pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968404     DOI: 10.1160/TH05-01-0006

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor.

Authors:  Beatriz Sánchez-Solana; Mona Motwani; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

2.  Thrombin stimulation of inflammatory breast cancer cells leads to aggressiveness via the EGFR-PAR1-Pak1 pathway.

Authors:  Kazufumi Ohshiro; Tri M Bui-Nguyen; Reddy S Divijendra Natha; Arnold M Schwartz; Paul Levine; Rakesh Kumar
Journal:  Int J Biol Markers       Date:  2012-12-27       Impact factor: 2.659

3.  FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.

Authors:  E Eroume A Egom; Yunbo Ke; Hanny Musa; Tamer M A Mohamed; Tao Wang; Elizabeth Cartwright; R John Solaro; Ming Lei
Journal:  J Mol Cell Cardiol       Date:  2009-10-21       Impact factor: 5.000

4.  Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.

Authors:  Kai Mao; Satoru Kobayashi; Zahara M Jaffer; Yuan Huang; Paul Volden; Jonathan Chernoff; Qiangrong Liang
Journal:  J Mol Cell Cardiol       Date:  2007-12-03       Impact factor: 5.000

5.  Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.

Authors:  Emmanuel Eroume A Egom; Tamer M A Mohamed; Mamas A Mamas; Ying Shi; Wei Liu; Debora Chirico; Sally E Stringer; Yunbo Ke; Mohamed Shaheen; Tao Wang; Sanoj Chacko; Xin Wang; R John Solaro; Farzin Fath-Ordoubadi; Elizabeth J Cartwright; Ming Lei
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

6.  The secret life of kinases: functions beyond catalysis.

Authors:  Jens Rauch; Natalia Volinsky; David Romano; Walter Kolch
Journal:  Cell Commun Signal       Date:  2011-10-28       Impact factor: 5.712

7.  Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension.

Authors:  Aiko Ogawa; Amy L Firth; Sanae Ariyasu; Ichiro Yamadori; Hiromi Matsubara; Shanshan Song; Dustin R Fraidenburg; Jason X-J Yuan
Journal:  Physiol Rep       Date:  2013-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.